
Our Mission
We translate the latest peer-reviewed research into clear, honest migraine guidance, reviewed by a board-certified neurologist on our team, and we keep it free.
Cerebral Torque's mission is to make high-quality migraine education accessible to all, free of charge. Working with a board-certified neurologist, we developed premium, evidence-based supplements for migraine support. The revenue from these products enables us to provide comprehensive, evidence-based migraine education without paywalls.
By reinvesting our profits into educational resources and product development, we empower the migraine community with both knowledge and practical solutions to improve their quality of life.

Free Migraine Education on YouTube
Cerebral Torque delivers research-backed breakdowns and myth-busting content to help migraine patients and future clinicians understand the disease. Subscribe for the latest in migraine science, treatment updates, and evidence-based solutions.
Watch on YouTubeMon, Aug 17, 26
Does Ginger Actually Help Migraine? A New Review Finally Grades the Evidence
A new BMJ Evidence-Based Medicine review pooled 8 randomized trials of ginger for migraine and graded every outcome as low or very low certainty. Here is what that means and...
Mon, Aug 10, 26
Gepants for Migraine: Atogepant & Rimegepant Evidence
A new review of 16 randomized trials breaks down how the gepants atogepant and rimegepant perform for migraine prevention and acute treatment. Here is what the evidence shows on efficacy,...
Mon, Aug 10, 26
Semaglutide (Ozempic, GLP-1) and Migraine: What a 189,000-Person Study Found
A nationwide Danish study of 189,392 adults found that starting weight-loss semaglutide was followed by a gradual 7% reduction in triptan use over 12 months. Here is what the findings...
Mon, Aug 03, 26
Blood Thinners for Migraine With a PFO: What a 1,000-Person Trial Found
A new BMJ randomized trial in 1,000 adults with migraine and a patent foramen ovale found rivaroxaban beat metoprolol for migraine prevention, with aspirin and clopidogrel close behind. Here is...

